Clinical Trial Update: Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating postoperative radiation therapy with hormonal therapy and concurrent docetaxel for high-risk prostate cancer; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Hormonal Therapy

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-24